The contract manufacturing firm SMC Ltd. has opened a new pharmaceutical development subsidiary known as Cambridge Pharma in Cambridge Research Park.
The Cambridge Pharma facility will include sterile fill-finish offerings, a process development laboratory and an analytical laboratory. The company can fill batches of 100 to 10,000 units.
It also will offer process development, scale up services, quality control and stability testing. In addition, the new location will offer Qualified Person (QP) release of clinical trial supplies.
The 20,000 ft² facility is located less than 10 miles away from the city center of Cambridge, UK.
“We value pharmaceutical partnerships and continue to expand services in development, manufacturing and analytical testing to help accelerate drug product development,” said Chetan N. Patel, owner and CEO of SMC Group. “We are proud to launch ‘Cambridge Pharma’ as a part of our continued focus, growth and commitment to pharm…